Related Experiment Video
Updated: Oct 30, 2025
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Validity of Random Triglyceride Levels in Infants Receiving Parenteral Nutrition
Mohammad Y Bader1,2, Melanie A Lam3, Fernando Munoz1,2
1Department of Pediatrics, University of Arizona Health Sciences, Tucson, AZ, United States.
Insights
For neonates receiving parenteral nutrition, random triglyceride (TG) levels are as effective as fasting TG levels for monitoring intravenous lipid emulsions (IL). This finding supports routine laboratory draws for managing IL therapy in infants.
Area of Science:
- Neonatal Medicine
- Clinical Chemistry
- Nutritional Science
Background:
- Intravenous lipid emulsions (IL) are crucial for parenteral nutrition (PN) in neonates, providing essential fatty acids and meeting metabolic needs.
- Ineffective IL metabolism in critically ill neonates can cause hypertriglyceridemia, leading to complications like increased pulmonary vascular resistance and platelet dysfunction.
- Serum triglyceride (TG) levels are used to assess lipid tolerance, but optimal monitoring strategies, including timing and target ranges, remain debated and unstandardized.
Purpose of the Study:
- To compare fasting and non-fasting triglyceride (TG) levels in neonates receiving intravenous lipid emulsions (IL) as part of parenteral nutrition (PN).
- To determine if random TG measurements are a suitable alternative to fasting TG measurements for managing IL therapy in infants.
- To evaluate the impact of IL administration timing on TG level interpretation.
Main Methods:
- A single-center, retrospective study involving newborn infants receiving PN.
- Fasting and non-fasting TG levels were collected during the same IL infusion (2-3g/kg/day).
- Statistical analysis included student t-tests, chi-squared tests, and logistic regression to compare TG levels and assess outcomes.
Main Results:
- Forty infants were included, with a mean gestational age of 29.5 weeks and birth weight of 1.3 kg.
- The mean difference between fasting and non-fasting TG levels was -18.6 mg/dL (p=0.03), indicating no significant clinical difference for management.
- Randomly drawn TG levels during IL infusion were comparable to fasting levels, supporting their use in routine monitoring.
Conclusions:
- There is no significant difference in managing intravenous lipid emulsions (IL) based on whether triglyceride (TG) levels are drawn randomly or while fasting.
- Obtaining TG levels during routine laboratory draws is appropriate for monitoring IL therapy in neonates.
- Continuous IL administration over 24 hours does not appear to interfere with the interpretation of TG levels.
Abstract:
Background: Intravenous lipid emulsions (IL) are an important part of parenteral nutrition (PN) to meet essential fatty acid (EFA) requirements and metabolic demands of neonates and preterm infants. Some critically-ill neonates may not metabolize IL effectively which can lead to hypertriglyceridemia. Risks associated with this include increased pulmonary vascular resistance, displaced bilirubins, and platelet or macrophage dysfunction. Serum triglyceride (TG) concentration is used as a marker for lipid tolerance and predictor of potential complications involved with IL administration, but the clinical significance of this is still debated. Management of TG levels with regard to timing of laboratory tests, the ideal goal range, and duration of infusion of IL varies across institutions and is not standardized. Methods: Single-center, retrospective study of newborn infants receiving parenteral nutrition (PN). Fasting and non-fasting TG levels were drawn during the same lipid infusion of 2-3g/kg/day. The primary outcome was the difference between fasting and non-fasting TG levels. Statistical assessment of continuous data was done with student t-test and nominal data was evaluated using X2-test and logistic regression. Results: Forty infants were included with mean gestational age at birth of 29.5 ± 3.4 weeks and mean birth weight of 1.3 ± 0.5 kg. Mean time between lab draws while on same IL dose was 11.6 ± 0.2 h with resulting mean fasting and non-fasting (random) TG levels 82 ± 40 mg/dL (95% CI 68.4, 97.6) and 101 ± 40 mg/dL (95% CI 88.5, 115.8), respectively. Mean difference between TG levels during lipid-free interval and during infusion was -18.6 ± 51.2 mg/dL (95% CI -35.0, -2.3; p = 0.03). Conclusion: We concluded there is no difference in the management of IL, when TG level was drawn randomly or as fasting sample. Obtaining TG level during routine lab draws is appropriate. We extrapolated that the administration of IL over 24 h will not interfere with TG level.
Related Concept Videos
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
01:27Parentral Nutrition: Centeral and Peripheral Parental Nutrition
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism